Physician profile
William E Costanzo
NPI 1376531517
$1,295.55
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $502 · 2020: $119 · 2021: $242 · 2022: $335 · 2023: $45.41 · 2024: $52.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $98.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $98.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $188.48 | 2019-2022 | |
| Pfizer INC. | $174.40 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $154.94 | 2019-2022 | |
| Amgen INC. | $146.32 | 2019-2024 | Repatha |
| Merck Sharp & Dohme LLC | $115.43 | 2021-2023 | Verquvo |
| Novartis Pharmaceuticals Corporation | $98.90 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $57.60 | 2019 | |
| Sanofi-Aventis U.S. LLC | $53.35 | 2019-2022 | |
| Medtronic, INC. | $45.58 | 2022 | |
| Boston Scientific Corporation | $41.73 | 2022-2024 | Watchman Flx |
| Astrazeneca Pharmaceuticals LP | $36.02 | 2020-2022 | |
| Abbott Laboratories | $33.86 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $30.63 | 2019-2023 | Lifevest |
| Esperion Therapeutics, INC. | $27.56 | 2021 | |
| Amarin Pharma, INC. | $27.53 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $23.67 | 2019 | |
| Astellas Pharma US INC | $13.73 | 2019 | |
| Recor Medical INC | $13.57 | 2024 | Paradise Renal Denervation System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Costanzo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.